The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17575500

Download in:

View as

General Info

PMID
17575500